NCT05439291

Brief Summary

The goal is to evaluate whether surgical excision of the pilonidal disease is needed after resolution of the initial symptoms when the patient follows regular hair removal regimen such as laser epilation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Jul 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Jul 2022Jan 2027

First Submitted

Initial submission to the registry

June 9, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 30, 2022

Completed
19 days until next milestone

Study Start

First participant enrolled

July 19, 2022

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

November 22, 2024

Status Verified

November 1, 2024

Enrollment Period

4.5 years

First QC Date

June 9, 2022

Last Update Submit

November 20, 2024

Conditions

Keywords

Pilonidal SurgeryPilonidal ExcisionPilonidal recurrence

Outcome Measures

Primary Outcomes (1)

  • Number of participants with recurrent symptoms of pilonidal disease

    Up to 1 year

Secondary Outcomes (4)

  • Number of participants requiring antibiotic treatment

    Up to 1 year

  • Time taken off from school or work due to pilonidal disease

    Up to 1 year

  • Effect on parent's daily activities

    Baseline to 1 year

  • Number of participants requiring additional surgical intervention

    Up to 1 year

Study Arms (2)

Regular epilation regimen only

ACTIVE COMPARATOR
Procedure: Regular Epilation Regimen

Regular epilation regimen with surgical excision

ACTIVE COMPARATOR
Procedure: Regular Epilation RegimenProcedure: Surgical excision

Interventions

Epilation using laser device

Regular epilation regimen onlyRegular epilation regimen with surgical excision

Excision of pilonidal pit with trephine

Regular epilation regimen with surgical excision

Eligibility Criteria

Age8 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients at Stanford Healthcare with pilonidal disease.
  • Patients over the age of 8yrs.

You may not qualify if:

  • Inability to read, write or understand English \*\*\*or Spanish
  • Intellectual disability precluding the patient from being able to comprehend or respond to the questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University School of Medicine

Palo Alto, California, 94304, United States

RECRUITING

Study Officials

  • Bill Chiu, MD

    Stanford University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The research will consist of randomized 1:1 controlled trial comparing regular epilation regimen only vs. regular epilation regimen with surgical excision
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Surgery

Study Record Dates

First Submitted

June 9, 2022

First Posted

June 30, 2022

Study Start

July 19, 2022

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Last Updated

November 22, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations